Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02196038 · ClinicalTrials.gov registry record · NA
A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT02196038: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT02196038 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 349 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02196038, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients, is a multicenter, randomized, attention-controlled, single-blind trial designed to examine the hypothesis that, in addition to standard care, a novel, tailored, progressive, multi-domain rehabilitation intervention administered to older patients with acute decompensated heart failure (ADHF) beginning early during hospitalization and continuing for 12 weeks will improve physical function and key clinical outcomes, including the rate of rehospitalization.
Primary Outcome
The Short Physical Performance Battery is scored on a scale of 0-12, with a higher score indicating better physical function.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL multi-domain rehabilitation intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2014-09 |
| Est. Completion | 2020-07-27 |
| Phase | NA |
What the finished NCT02196038 record still lists
NCT02196038 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT02196038 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02196038 about?
NCT02196038 is a clinical study titled "A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients". REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients, is a multicenter, randomized, attention-controlled, single-blind trial designed to examine the hypothesis that, in addition to standard care, a novel, tailored, progressive, multi-domain rehabilitation intervention ad...
What is the current status of trial NCT02196038?
This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2014-09. Estimated completion is 2020-07-27.
What interventions are being tested in trial NCT02196038?
The interventions under investigation include: Attention Control (BEHAVIORAL), multi-domain rehabilitation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02196038?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02196038's enrollment target sits among peer trials
349 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia